An impurity was found in Pfizer’s heart and blood pressure medication Accupril that has led to a recall of several lots of the drug. The contaminant, known as a nitrosamine, can be carcinogenic at high levels and can increase a patient’s risk of developing cancer over time.
Patients are advised against stopping their medication at this time. Rather, those that are concerned that they may have pills from contaminated ...
continue reading...
Drug manufacturer Pfizer has moved to recall several lots of blood pressure pills over concerns that the medication may have been tainted with a carcinogenic contaminant. The affected medications include Accuretic, which is a tablet distributed by Pfizer itself, as well as a line of medications distributed by a second manufacturer known as Greenstone. The Greenstone lots include a pill that combines quinapril hydrochloride and hydrochlorothiazide as ...
A U.S. District Court judge in Florida recently dismissed a number of claims against generic manufacturers of Zantac products, as well as various packagers, retailers, and distributors of the products. Ranitidine is the active ingredient in the heartburn medications and is at the center of a firestorm of controversy over concerns of contamination with a carcinogenic compound called N-nitrosodimethylamine, or NDMA.
Thousands of plaintiffs across the ...
continue reading...Two lots of diabetes drug metformin produced by Kansas City, Missouri drug maker Nostrum Laboratories are being pulled from pharmacy shelves over concerns that they might be contaminated with a cancer-causing compound. The compound, known as NDMA or nitrosamine, was detected in the company’s 750mg HCI extended-release tablets at levels that exceed federal regulations.
NDMA is a naturally occurring chemical that is found in everything from the fruits you ...
continue reading...
Diabetics who take metformin will want to contact their healthcare providers after multiple recalls of the drug have occurred due to the discovery of elevated levels of a cancer-causing compound. Multiple lots of the extended release version of the drug from multiple manufacturers tested positive for the presence of NDMA, or N-Nitrosodimethylamine, in amounts that exceed FDA regulations.
According to the FDA, humans should be able to tolerate up ...
continue reading...2020 has not been kind to Sanofi’s flagship heartburn medication Zantac. When reports first surfaced of contamination of the medication with a known carcinogen, attention immediately turned to the labs that made ranitidine, the active ingredient in Zantac. It wasn’t until researchers discovered that Zantac could be producing the carcinogen itself that calls began for a recall of the drug. The mechanism that could lead to such an occurrence, however, has not ...
